New study aims to unlock secrets of rare muscle disease
NCT ID NCT04792931
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is building a library of information and samples from 60 adults with suspected autoimmune myopathy, a rare muscle disease. Researchers will collect blood, urine, stool, and muscle tissue, along with medical data, to better understand the condition. The goal is to improve diagnosis and future treatments.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could improve understanding of autoimmune myopathies and help develop better diagnostic tools or treatments in the future.
- What could go wrong
- This is an observational study, not a treatment trial. It is small (60 participants) and only at one hospital, so findings may not apply to everyone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IDIOPATHIC INFLAMMATORY MYOPATHIES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU de BREST
RECRUITINGBrest, 29200, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Immune clues in the blood may foretell heart trouble
- Can a simple blood test unlock the secrets of brain autoimmune diseases?
- Engineered immune cells take aim at Hard-to-Treat muscle disease
- Engineered immune cells take aim at childhood autoimmune diseases
- New tool could predict who will suffer from steroid side effects
- HIV drug repurposed to fight muscle inflammation